PHASE 2 TRANSCRANIAL PROBE
K-Number: K894163 · 1989-09-12
Advertisement
Device Summary
Frequently Asked Questions
What is the PHASE 2 TRANSCRANIAL PROBE?
PHASE 2 TRANSCRANIAL PROBE is a medical device that received FDA 510(k) clearance on 1989-09-12. The listed applicant is Biosound, Inc.. The 510(k) number is K894163.
When did PHASE 2 TRANSCRANIAL PROBE receive FDA 510(k) clearance?
PHASE 2 TRANSCRANIAL PROBE received FDA 510(k) clearance on 1989-09-12, under 510(k) number K894163.
Who is the listed applicant for PHASE 2 TRANSCRANIAL PROBE?
The FDA 510(k) record lists Biosound, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for PHASE 2 TRANSCRANIAL PROBE?
The FDA product code for PHASE 2 TRANSCRANIAL PROBE is IYN.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Biosound, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: IYN)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement